Optimal deployment of limited vaccine supplies to combat mpox
Berry, M. T.; MacIntyre, C. R.; Cromer, D.; Hacker, A.; Davenport, M. P.; Khoury, D. S.
10.1101/2024.11.03.24316551 medRxivShow abstract
Mpox outbreaks in Central Africa have been declared a public health emergency of international concern by the World Health Organization. Fortunately, real-world effectiveness studies of the MVA-BN vaccine indicate that it has an effectiveness of 74% after one dose, and 82% after two doses against mpox. However, given the very limited supply of vaccines in Central Africa, there remain questions around the optimal deployment of limited MVA-BN doses. In this study, we consider whether more mpox cases might be averted by following the traditional two-dose vaccine regimen (4 week dosing interval), or by giving a single dose of MVA-BN to as many individuals as possible. We find that the optimal strategy depends on both, (i) the degree to which a subpopulation might be at higher risk of mpox, or severe mpox, infections, and (ii) how long ago the first dose was administered to the most at-risk subpopulation.
Matching journals
The top 1 journal accounts for 50% of the predicted probability mass.
Similar papers in this journal
- Maternal pertussis immunization and the blunting of routine vaccine effectiveness: A meta-analysis and modeling study 96%
- Optimizing vaccine allocation for COVID-19 vaccines: potential role of single-dose vaccination 96%
- Behaviour, booster vaccines and waning immunity: modelling the medium-term dynamics of SARS-CoV-2 transmission in England in the Omicron era 96%
Similar papers in this journal
- SARS-CoV-2 transmission dynamics in South Africa and epidemiological characteristics of the Omicron variant 94%
- Quantifying the relationship between SARS-CoV-2 viral load and infectiousness 93%
- Reducing RSV hospitalisation in a lower-income country by vaccinating mothers-to-be and their households 93%
Similar papers in this journal
Similar papers in this journal
- The hyper-transmissible SARS-CoV-2 Omicron variant exhibits significant antigenic change, vaccine escape and a switch in cell entry mechanism 92%
- Effectiveness of mRNA and ChAdOx1 COVID-19 vaccines against symptomatic SARS-CoV-2 infection and severe outcomes with variants of concern in Ontario 92%
- Identifying the role of household immunity in driving individual dengue virus infection risk 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.